InsiderTrades

Form 4 for HALO HALOZYME THERAPEUTICS, INC.

Accepted 2024-02-20 00:00:00 ET · period of report 2024-02-16 · accession 0001415889-24-004477 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-02-20 2024-02-16 HALO LaBarre Michael J. SVP, Chief TECHNICAL Off M - OptEx $0.00 +10.4K 171.2K +6% $0
DM 2024-02-20 2024-02-16 HALO LaBarre Michael J. SVP, Chief TECHNICAL Off F - Tax $36.10 -5,257 169.1K -3% -$189.8K
DM 2024-02-20 2024-02-16 HALO LaBarre Michael J. SVP, Chief TECHNICAL Off M - OptEx $0.00 -10.4K 12.2K -46% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-16 M A 6,112 $0.00 170,080 D — —
2 Common Common Stock 2024-02-16 F D 3,097 $36.10 166,983 D — — (F1) The reported disposition of 3,097 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
3 Common Common Stock 2024-02-16 M A 4,264 $0.00 171,247 D — —
4 Common Common Stock 2024-02-16 F D 2,160 $36.10 169,087 D — — (F2) The reported disposition of 2,160 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
5 Derivative Restricted Stock Units 2024-02-16 M D 4,264 $0.00 12,789 D $0.00 · — to — 4,264 Common Stock (F3) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
6 Derivative Restricted Stock Units 2024-02-16 M D 6,112 $0.00 12,224 D $0.00 · — to — 6,112 Common Stock (F3) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.